Ovid Therapeutics Ownership | Who Owns Ovid Therapeutics?

Overview Forecast RevenueFinancials Chart

Ovid Therapeutics Ownership Summary

Ovid Therapeutics is owned by 2877.10% institutional investors, 16.31% insiders. Takeda pharmaceutical is the largest institutional shareholder, holding 602.56% of OVID shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.52% of its assets in Ovid Therapeutics shares.

OVID Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Ovid Therapeutics	2877.10%	16.31%	-2793.41%
Sector	Healthcare Stocks	488.17%	11.08%	-399.26%
Industry	Biotech Stocks	306.59%	11.10%	-217.69%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Takeda pharmaceutical	7.53M	602.56%	$2.49M
Bvf inc/il	3.85M	308.31%	$1.27M
Sio capital management	2.23M	178.56%	$736.34K
Acadian asset management	2.11M	168.67%	$693.00K
Kennedy capital management	1.50M	120.19%	$495.62K
Driehaus capital management	1.40M	112.02%	$461.92K
Blackrock funding, inc. /de	1.37M	109.52%	$451.64K
Adage capital partners gp	1.15M	92.00%	$379.38K
Tls advisors	680.97K	54.48%	$225.00K
Affinity asset advisors	667.52K	53.40%	$220.21K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Takeda pharmaceutical	7.53M	12.71%	$2.49M
Tls advisors	680.97K	0.70%	$225.00K
Madison avenue partners, lp	3.72M	0.37%	$3.48M
Sio capital management	2.23M	0.28%	$736.34K
Rubric capital management lp	5.32M	0.06%	$4.96M
Velan capital investment management lp	70.00K	0.06%	$65.36K
Artal group	2.50M	0.05%	$1.92M
Bvf inc/il	3.85M	0.05%	$1.27M
Affinity asset advisors	667.52K	0.03%	$220.21K
Kennedy capital management	1.50M	0.01%	$495.62K

Top Buyers

Holder	Shares	% Assets	Change
State street	1.35M	-	198.72K
Marshall wace, llp	164.72K	0.00%	164.72K
Y-intercept (hong kong)	160.31K	0.00%	160.31K
Hrt financial lp	123.32K	0.00%	97.72K
Qube research	72.74K	-	72.74K

Top Sellers

Holder	Shares	% Assets	Change
Ecor1 capital	-	-	-6.12M
Siren	-	-	-2.85M
Blackrock funding, inc. /de	1.37M	-	-2.49M
Ubs oconnor	-	-	-943.42K
Blue owl capital lp	-	-	-864.82K

New Positions

Holder	Shares	% Assets	Change	Value
Marshall wace, llp	164.72K	0.00%	164.72K	$54.36K
Y-intercept (hong kong)	160.31K	0.00%	160.31K	$52.88K
Qube research	72.74K	-	72.74K	$24.00K
Velan capital investment management lp	70.00K	0.06%	70.00K	$65.36K
Susquehanna group, llp	45.12K	-	45.12K	$42.13K

Sold Out

Holder	Change
Newedge advisors	-4.00
Advisor group	-5.00
Ifp advisors	-8.00
Nelson, van denburg & campbell wealth management group	-10.00
Frazier financial advisors	-10.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	69	-15.85%	35,963,757	-7.47%	2,877	297.56%	34	17.24%	21	-25.00%
Mar 31, 2025	83	-	46,400,658	-2.45%	37	0.83%	29	-21.62%	28	33.33%
Dec 31, 2024	28	-63.16%	10,144,389	-73.85%	14	0.48%	13	-69.05%	7	-53.33%
Sep 30, 2024	76	2.70%	38,794,655	0.78%	54	1.84%	42	16.67%	15	-40.00%
Jun 30, 2024	74	-8.64%	38,492,740	-9.60%	54	1.50%	36	-5.26%	25	4.17%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	1.79M	2.52%	-
Vanguard Total Stock Mkt Idx Inv	1.75M	2.47%	-38.35K
Kennedy Micro Cap	1.04M	1.46%	-64.12K
Fidelity Small Cap Index	578.63K	0.81%	-
Vanguard Institutional Extnd Mkt Idx Tr	563.03K	0.79%	-256.56K
State St Russell Sm/Mid Cp® Indx SL Cl I	525.80K	0.74%	-
State St Russell Sm/Mid Cp® Indx NL Cl C	525.80K	0.74%	-
MEDICAL BioHealth EUR Acc	503.85K	0.71%	-
Kennedy Micro Cap Opportunities	465.48K	0.65%	82.64K
iShares Biotechnology ETF	393.77K	0.55%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Feb 26, 2025	ALEXANDER MARGARET A.	President and COO	Sell	$2.96K
Feb 26, 2025	Rona Jeffrey A	CBFO	Sell	$2.19K
Jan 27, 2025	ALEXANDER MARGARET A.	President and COO	Buy	$4.97K
Mar 18, 2024	LEVIN JEREMY M	CEO	Buy	$50.36K
Sep 12, 2022	Tardio Jason	Chief Operating Officer	Sell	$37.29K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	1	2
2024 Q4	-	-
2024 Q3	-	-
2024 Q1	1	-
2023 Q4	-	-

OVID Ownership FAQ

Who Owns Ovid Therapeutics?

Ovid Therapeutics shareholders are primarily institutional investors at 2877.10%, followed by 16.31% insiders and -2793.41% retail investors. The average institutional ownership in Ovid Therapeutics's industry, Biotech Stocks , is 306.59%, which Ovid Therapeutics exceeds.

Who owns the most shares of Ovid Therapeutics?

Ovid Therapeutics’s largest shareholders are Takeda pharmaceutical (7.53M shares, 602.56%), Bvf inc/il (3.85M shares, 308.31%), and Sio capital management (2.23M shares, 178.56%). Together, they hold 1089.43% of Ovid Therapeutics’s total shares outstanding.

Does Blackrock own Ovid Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Ovid Therapeutics.

Who is Ovid Therapeutics’s biggest shareholder by percentage of total assets invested?

Takeda pharmaceutical is Ovid Therapeutics’s biggest shareholder by percentage of total assets invested, with 12.71% of its assets in 7.53M Ovid Therapeutics shares, valued at 2.49M$.

Who is the top mutual fund holder of Ovid Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Ovid Therapeutics shares, with 2.52% of its total shares outstanding invested in 1.79M Ovid Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools